Condition
Silent Cerebral Infarct
Total Trials
5
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Unknown1
Active Not Recruiting1
Suspended1
Clinical Trials (5)
Showing 5 of 5 trials
NCT04808778Active Not Recruiting
Stroke Prevention in Young Adults With Sickle Cell Anemia
NCT05685069Recruiting
Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions
NCT04449523Recruiting
Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions
NCT05146037Not ApplicableUnknown
INTERvention With Cerebral Embolic Protection in Transcatheter Aortic Valve Implantation (INTERCEPTavi)
NCT04062539Suspended
Total Cerebral Protection With Embolic Protection Devices Thoracic Aortic Stenting
Showing all 5 trials